Effect of macrophage migration inhibitory factor (MIF) on acute graft-versus-host disease in a murine model of allogeneic stem cell transplantation.

[1]  K. Matsumoto,et al.  Elevated macrophage migration inhibitory factor (MIF) levels in the urine of patients with focal glomerular sclerosis , 2005, Clinical and experimental immunology.

[2]  J. Ferrara,et al.  The Pathophysiology of Acute Graft-versus-Host Disease , 2003, International journal of hematology.

[3]  R. Atkins,et al.  Blockade of Macrophage Migration Inhibitory Factor Does Not Prevent Acute Renal Allograft Rejection , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  C. Metz,et al.  CARDIAC ALLOGRAFT REJECTION IN THE ABSENCE OF MACROPHAGE MIGRATION INHIBITORY FACTOR , 2003, Transplantation.

[5]  C. Miracco,et al.  Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis , 2003, Annals of the rheumatic diseases.

[6]  R. Liang,et al.  Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients , 2002, Bone Marrow Transplantation.

[7]  T. Iwanaga,et al.  Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. , 2002, Gastroenterology.

[8]  S. Deventer,et al.  Development of chronic colitis is dependent on the cytokine MIF , 2001, Nature Immunology.

[9]  A. Satoskar,et al.  Migration-Inhibitory Factor Gene-Deficient Mice Are Susceptible to Cutaneous Leishmania major Infection , 2001, Infection and Immunity.

[10]  R. Atkins,et al.  Expression of macrophage migration inhibitory factor in human glomerulonephritis. , 2000, Kidney international.

[11]  J. Nishihira,et al.  Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[12]  M. Taniguchi,et al.  Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia , 2000, Immunology.

[13]  G. Hill,et al.  The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. , 2000, Blood.

[14]  N. Chao,et al.  Pathophysiologic mechanisms of acute graft-vs.-host disease. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  Atkins,et al.  Up‐regulation of macrophage migration inhibitory factor in acute renal allograft rejection in the rat , 1999, Clinical and experimental immunology.

[16]  M. Shlomchik,et al.  Prevention of graft versus host disease by inactivation of host antigen-presenting cells. , 1999, Science.

[17]  S. Onodera,et al.  High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints. , 1999, Cytokine.

[18]  A. Satoskar,et al.  Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in Sepsis , 1999, The Journal of experimental medicine.

[19]  R. Atkins,et al.  Macrophage migration inhibitory factor expression in human renal allograft rejection. , 1998, Transplantation.

[20]  R. Atkins,et al.  The Pathogenic Role of Macrophage Migration Inhibitory Factor in Immunologically Induced Kidney Disease in the Rat , 1997, The Journal of experimental medicine.

[21]  R. Bucala,et al.  Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome , 1997, Nature Medicine.

[22]  R. Bucala.  MIF rediscovered: cytokine, pituitary hormone, and glucocorticoid‐induced regulator of the immune response , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  J. Crawford,et al.  An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. , 1996, Blood.

[24]  R. Bucala,et al.  An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Bernhagen,et al.  An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction , 1996, The Journal of experimental medicine.

[26]  J. Bernhagen,et al.  The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor , 1994, The Journal of experimental medicine.

[27]  K. Tracey,et al.  MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia , 1993, Nature.

[28]  J. David.  Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[29]  B. Bloom,et al.  Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity , 1966, Science.

[30]  H. Deeg,et al.  Graft-versus-host disease: pathophysiological and clinical aspects. , 1984, Annual review of medicine.